Narwhal Capital Management increases AmSurg stake by 2.6% — 3 notes

During the third quarter of fiscal year 2016, Narwhal Capital Management increased its stake in Nashville, Tenn.-based AmSurg by 2.6 percent, according to The Cerbat-Gem.

Here are three notes:

1. The firm had a nearly $1.1 million stake in AmSurg at the end of Q3.

2. Citigroup rated AmSurg shares a "buy" rating on Sept. 26, 2016.

3. Citigroup set a $79 price target on AmSurg shares.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast